Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio

Bruker Corporation recently announced the signing of the definitive agreement to purchase 100 percent of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off the animal head. This enables simultaneous imaging and stimulation of three sub-types of neurons in up to four regions for flexible investigation of the central nervous system with single-neuron resolution in naturalistic behavior. This platform creates strong synergies with Bruker’s existing Ultima multiphoton solutions and newly acquired Inscopix head-mounted miniscopes.

Neurescence is a former participant in OBIO® Health to Business Bridge™ program (H2BB™) and OBIO® Business Development Skills Program (BDSP™)